Famciclovir and Penciclovir. The Mode of Action of Famciclovir Including Its Conversion to Penciclovir
Author:
- 1 April 1993
- journal article
- Published by SAGE Publications in Antiviral Chemistry and Chemotherapy
- Vol. 4 (2) , 67-84
Abstract
Famciclovir is the oral form of penciclovir, a highly selective antiherpesvirus agent. Both famciclovir and penciclovir are being evaluated in clinical studies. This review covers the conversion of famciclovir to penciclovir, the formation and stability of penciclovir-triphosphate, its effect on herpesvirus DNA polymerases and the inhibition of viral DNA synthesis in cell cultures. The conversion of famciclovir into penciclovir is described, emphasising work with human tissues and including the elucidation of the structures of its chiral monoacetylated derivatives. To reflect its metabolism during oral absorption, famciclovir was incubated in duodenal contents, extracts of intestinal wall and liver, and in blood. The major metabolic route was by de-acetylation followed by oxidation of the purine to form penciclovir. This work with human tissues was predictive of the major metabolic pathway in humans. Penciclovir is phosphorylated much more efficiently than acyclovir in herpesvirus-infected cells yet the host cell kinases phosphorylate the two compounds to a small but comparable extent. This highly preferential metabolism in herpesvirus infected cells is a major factor in its selective antiviral activity. The ( S) enantiomer of penciclovir-triphosphate is the major metabolite and it has good stability in HSV-1, HSV-2, and VZV infected cells. At the high concentrations found in infected cells, penciclovir-triphosphate was an effective inhibitor of viral DNA polymerases and of viral DNA synthesis. The efficient entrapment of the active moiety can account for the markedly better antiviral activity of penciclovir than acyclovir when infected cell cultures were treated for a short time. Such assays reflect more closely the clinical situation after oral dosing than do standard assays in which the test compounds are present continuously. The role of these studies in compound selection and development is discussed.Keywords
This publication has 30 references indexed in Scilit:
- Activity of penciclovir and acyclovir in DBA/2 mice infected intraperitoneally with HSV-1 (SC16) : M.R. Boyd, D. Sutton, and R.J. Ashton, SmithKline Beecham Pharmaceuticals, Epsom, Surrey, UK, KT18 5XQAntiviral Research, 1992
- Chemoenzymatic approach to the synthesis of the antiviral agents penciclovir and famciclovir in isotopically chiral [13C] labelled formJournal of the Chemical Society, Perkin Transactions 1, 1992
- Carba‐acyclonucleoside antiherpetic agentsJournal of Heterocyclic Chemistry, 1989
- Structural Requirements for Enzymatic Activation of Acyclonucleotide Analogues1989
- Prodrugs of the selective antiherpesvirus agent 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine (BRL 39123) with improved gastrointestinal absorption propertiesJournal of Medicinal Chemistry, 1989
- Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cellsAntimicrobial Agents and Chemotherapy, 1989
- Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine (BRL 39123) in animalsAntimicrobial Agents and Chemotherapy, 1988
- Some biological properties of BRL 42810, a well absorbed oral prodrug of the antiherpesvirus agent BRL 39123 : M.R. Boyd, R. Boon, S.E. Fowles, K. Pagano, D. Sutton, R.A. Vere Hodge and B.D. Zussman. Beecham Pharmaceuticals, Research Division, Great Burgh, Epsom, Surrey, United KingdomAntiviral Research, 1988
- Critical determinants of antiherpes efficacy of buciclovir and related acyclic guanosine analogsAntiviral Research, 1987
- Stereochemical considerations in the enzymatic phosphorylation and antiviral activity of acyclonucleosides. I. Phosphorylation of 2′-nor-2′-deoxyguanosineBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1987